LGD 4033 + Ostarine Tablets

LGD 4033 + Ostarine Tablets


Brand: Category Use Cases: , Form:

LGD 4033 + Ostarine tablets is offered in 2 variants: 20mg per tablet for 27 tablets, totaling 540mg and 20mg per tablet for 54 tablets, totaling 1080mg.

LGD 4033 is a novel nonsteroidal oral selective androgen receptor modulator being investigated as a potential treatment for muscle dystrophy and osteoporosis. Recent studies showed that LGD 4033 had a positive effect on muscle tissue in ovariectomized rats. The LGD treatment resulted in a higher number of capillaries in all muscles studied. Longer randomized trials and research could potentially evaluate its efficacy in improving physical function and health outcomes in select populations.

CAS Number 1165910-22-4
Molar Mass 338.253 g·mol−1
Chemical Formula C14H12F6N2O
IUPAC Name 4-[(2R)-2-[(1R)-2,2,2-trifluoro-1-hydroxyethyl]pyrrolidin-1-yl]-2-(trifluoromethyl)benzonitrile
CAS Number 1202044-20-9
Molar Mass 389.33g/mol-1
Chemical Formula C19H10D4F3N3O3
IUPAC Name 3-(4-cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide

Buy Now

onpeptides.com participates in the Amazon Associates Associates Program, an affiliate advertising program designed to provide a means for sites to earn commissions by linking to Amazon. This means that whenever you buy a product on Amazon from a link on here, we get a small percentage of its price.

onpeptides.com does not offer medical diagnosis or treatment advice we make no claims that the products referenced can cure, treat or prevent any conditions, including any conditions referenced on its website or in print materials.

This information has not been evaluated by the Food and Drug Administration (FDA).